AbbVie (ABBV) Stock Before Q2 Earnings: To Buy or Not to Buy?

AbbVie (ABBV) will report second-quarter earnings on Jul 25, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $14.05 billion and $2.56 per share, respectively.Though the company’s earnings estimates have declined from $11.27 per share to $10.81 for 2024 in the past 60 days, they have increased from $12.08 to $12.13 for 2025 during the same period. Image Source: Zacks Investment ResearchEarnings Surprise HistoryAbbVie’s performance has been impressive, with its earnin ...